LL
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Lysophosphatidylinositols Are Upregulated After Human β-Cell Loss and Potentiate Insulin Release | Diabetes |  | 2024 | 366 | 3 | ||
| Screening for new inhibitors of the human Mitochondrial Pyruvate Carrier and their effects on hepatic glucose production and diabetes | Biochimica et biophysica acta. G, General subjects | | 2023 | 93 | 0 | ||
| Circulating 1,5-anhydroglucitol as a biomarker of ß-cell mass independent of a diabetes phenotype in human subjects | The Journal of clinical endocrinology and metabolism | | 2022 | 418 | 2 | ||
| In vivo stabilization of OPA1 in hepatocytes potentiates mitochondrial respiration and gluconeogenesis in a prohibitin-dependent way | Journal of Biological Chemistry |  | 2019 | 457 | 151 | ||
| Reply to Mishra: prohibitin heterodimers—a complex time dependence for carcinogenesis | Journal of Biological Chemistry | | 2019 | 317 | 120 | ||
| Metabolomics identifies a biomarker revealing in vivo loss of functional ß-cell mass before diabetes onset | Diabetes | | 2019 | 384 | 1,034 | ||
| Liver Glutamate Dehydrogenase Controls Whole-Body Energy Partitioning Through Amino Acid-Derived Gluconeogenesis and Ammonia Homeostasis | Diabetes | | 2018 | 413 | 877 | ||
| Mitochondrial function and morphology in prohibitin 2 deleted ß-cells and hepatocytes | | 2017 | 777 | 13 |
